USSTOCK.TODAY
Market Closed
Log in Sign up

AbbVie and Novo Nordisk: A Comparison of 2026 Healthcare Investments

The Motley Fool +1 ·

NVO Novo Nordisk ADR
$38.06 -1.35%
View chart & analysis →
  1. 1AbbVie revenue for fiscal year 2025 was approximately $61.2 billion.
  2. 2Novo Nordisk revenue for fiscal year 2025 increased by approximately 6.4% year-over-year.
  3. 3AbbVie acquired Apogee Therapeutics for $10.9 billion.

So what's the key point?

AbbVie recorded $61.2 billion in revenue, while Novo Nordisk revenue grew by 6.4%. AbbVie expanded its business by acquiring Apogee Therapeutics.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

Comparison of Earnings and Investment Value: Bristol Myers Squibb vs. Novo Nordisk Nasdaq +1 · 3d agoUBS Analyst Classifies Novo Nordisk as Value Trap Nasdaq +2 · 5d agoCiti Downgrades NXP Semiconductors and Lowers Price Target MarketWatch +2 · 5d ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news